UPDATE : Tuesday, July 23, 2019
상단여백
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’
Kolon Life Science CEO said he would seek an administrative suit against th...
by Lee Hye-seon  |  2019-07-03 11:52
라인
SNUH will continue to operate Sheikh Khalifa Special Hospital
Seoul National University Hospital (SNUH) said it has won the renewal of th...
by Lee Han-soo  |  2019-07-02 17:07
라인
‘Patients with myeloproliferative neoplasm unaware of cause before diagnosis’
Most patients with a myeloproliferative neoplasm (MPN) were unaware of the ...
by Kim Yun-mi  |  2019-07-02 16:42
라인
Handok releases Fabry disease treatment
Handok said Tuesday that it has rolled out Galafold, a Fabry disease treatm...
by Lee Han-soo  |  2019-07-02 16:19
라인
'Pituitary tumor can impair eyesight'
A research team at Kyung Hee University Hospital at Gangdong has discovered...
by Lee Han-soo  |  2019-07-02 15:28
라인
26 new drugs approved in H1
Twenty-six new pharmaceutical products received approval in Korea in the fi...
by Lee Hye-seon  |  2019-07-02 14:31
라인
Korean, US national cancer centers co-research proteogenomics
The National Cancer Center (NCC) has signed a memorandum of understanding w...
by Lee Han-soo  |  2019-07-02 12:11
라인
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How?
Yuhan Corp. recently made headlines by signing an $870 million licensing de...
by Jeong Sae-im  |  2019-07-02 12:11
라인
Regulator OKs nation’s 1st clinical trial for ‘digital treatment’
The Ministry of Food and Drug Safety has approved Nunaps’ clinical trial of...
by Lee Han-soo  |  2019-07-01 16:35
라인
[Special]Korean drugmakers harbor undue expectations on global blockbusters
“The pharmaceutical and biotech industry will lead our economy soon. Even n...
by Jeong Sae-im  |  2019-07-01 16:19
라인
Huons launches new osteoarthritis treatment
Huons said that it has launched “Hi Hyal Once,” an osteoarthritis treatment...
by Lee Han-soo  |  2019-07-01 15:13
라인
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz
The Korean branch of Eli Lilly said that it had gained additional reimburse...
by Lee Han-soo  |  2019-07-01 14:27
라인
BMS Korea files administrative suit to appeal Eliquis price cut
The price reduction of BMS Korea Pharmaceutical’s blood thinner Elidquis ha...
by Kim Yun-mi  |  2019-07-01 14:16
라인
Multinationals face suspension of drug imports
The regulator ordered multinational pharmaceutical firms, including MSD Kor...
by Lee Hye-seon  |  2019-07-01 14:12
라인
Yuhan signs $870 million licensing deal with Boehringer Ingelheim
Yuhan announced a joint development and licensing agreement with Boehringer...
by Lee Han-soo  |  2019-07-01 14:09
라인
'Proteogenomics will improve ability to prevent, diagnose and treat cancer at molecular level'
With recent advancements in sequencing technologies, scientists are no long...
by Lee Han-soo  |  2019-06-28 17:43
라인
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular
As physicians have increasingly recommended glucagon-like peptide-1 (GLP-1)...
by Kim Yun-mi  |  2019-06-28 16:12
라인
BNO BIO to invest $1 million in Israeli biotech venture
BNO BIO, a joint venture between Bukwang Pharm and chemical and energy comp...
by Jeong Sae-im  |  2019-06-28 16:10
라인
Government to help cover costs for injuries from side effects
The government said it would help patients get compensation for diseases ca...
by Lee Hye-seon  |  2019-06-28 12:30
라인
SNUH finds clue for early diagnosis of undifferentiated thyroid cancer
Researchers at Seoul National University Hospital and Macrogen have discove...
by Lee Han-soo  |  2019-06-28 11:05
여백
여백
여백
Back to Top